-
Lancet: Maintaining low-dose glucocorticoid therapy is more effective in controlling symptoms in patients with low-disease activity, rheumatoid arthritis.
Time of Update: 2020-07-30
the treatment of 99 patients in the persinisone maintenance group (defined as 24 weeks of low disease activity, no rheumatoid arthritis attacks at 24 weeks, no confirmed adrenal insufficiency), and 85 patients in the pernel reduction group (relative risk 0.83).
-
Why is a plant-based diet essential to the health of the body?
Time of Update: 2020-07-30
!--webeditor: "page title" -- We all know that plant-based diets are good for the health of the body, so is there some scientific basis for this? In this article, the small editor on the compilation o
-
Nat Commun: Revealing how to mobilize immune cells against infection!
Time of Update: 2020-07-30
team found that the structure inside the lymph nodes leaves chemical signals that guide B cells through these complex tissues, like miniature lighthouses that guide safe navigation.
-
Ann Rheum Dis: The safety and efficacy of systemic lupus in children with intravenous bellimumonobresis.
Time of Update: 2020-07-30
The !---- ongoing Phase 2, randomized, placebo-controlled, double-blind study assessed the efficacy, safety, and pharmacokinetics of intravenous bellimuazumab in children with systemic lupus erythematosus (cSLE).
main endpoint: SLE Respondent Index (SRI4) Response Rate (Week 52).
-
Semin Arthritis Rheu: Acute respiratory viral infection during rheumatic treatment.
Time of Update: 2020-07-30
study reviewed the incidence and severity of acute respiratory virus adverse events associated with rheumatic therapy.
the study found that certain drugs increase the risk of acute respiratory infections.
-
PNAS: Research reveals the mechanism of systemic allergic reactions.
Time of Update: 2020-07-30
now, a team of researchers led by LMU immunopharmacologist Susanna Zierler and pharmacologist found that the activity of certain ion channel proteins in fat cells plays an important role in preventing abnormal and allergic reactions and ensuring that the immune response is not over-regulated.
-
Nature: Discover the most effective SARS-CoV-2 virus neutralizing antibodies!
Time of Update: 2020-07-30
27, 2020 /PRNewswire/ -- Researchers at Columbia University's Irvine Medical Center isolated the most effective SARS-CoV-2 virus neutral antibodies to date from several PATIENTs with COVID-19.
-
For the new coronavirus SARS-CoV-2/COVID-19, cell journal's latest research progress at a glance (No. 3)
Time of Update: 2020-07-30
http://photos.!--.s---- July 28, 2020 /--- PRNewswire/ -- Since December 8, 2019, several cases of pneumonia with an unknown cause have been reported in Wuhan, Hubei Province, China. most of the pati
-
Cell: China has developed a new mRNA new coronapneumonia vaccine, which can maintain thermal stability in vitro for at least a week.
Time of Update: 2020-07-30
July 27, 2020 /prNewswire --- In a new study, researchers from the Chinese Academy of Military Medical Sciences, Suzhou Aibo Biotech Co., Ltd., the China Food and Drug Research Institute, Tsinghua University and the Institute of Life Almanology of the Institute of Military Medicine reported that an experimental SARS-CoV-2 vaccine based on messenger RNA (mRNA) can cause protective immune responses in non-human primates.
-
Sci Rep: A comparison of rheumatoid arthritis in the treatment of rheumatoids with a single drug called leflumit.
Time of Update: 2020-07-30
After 3 months of , there were no significant differences in the activity scores of 28 joint diseases (DAS28), health assessment questionnaire (HAQ), blood sink (ESR) and C-reactive protein (CRP) in the single-drug treatment group and the combined treatment group (P.05).
-
Nature: Longitudinal analysis showed that patients with severe COVID-19 suffered from immune dysfunction.
Time of Update: 2020-07-30
28, 2020 // --- In a new study, researchers at Yale University in the United States found that the differential immune system responses of PATIENTs with COVID-19 help predict who will experience moderate and severe disease consequences.
-
J Rheumatol: Comparison of abdominal obesity with the risk of rheumatoid arthritis in ordinary obese women.
Time of Update: 2020-07-30
abdominal obesity is associated with an increased RA risk in young and middle-aged women, especially serotonin-positive RA, but in addition to common obesity, abdominal obesity does not cause RA risk alone.
-
Gout encountertheseative, medication will be more careful!
Time of Update: 2020-07-30
▎ agiotensin II receptor antagonist (ARB) chloratan promotes uric acid excretion by inhibiting the activity of uric acid transporter 1 (URAT1), its uric acid reduction effect is dose-dependent, and by reducing blood uric acid levels to reduce cardiovascular events, can be used for gout or HUA combined hypertension .
-
NATURE: Vertical analysis, the new crown critical patients of the immune disorder situation is what?
Time of Update: 2020-07-30
after an increase in early cytokines, patients with moderate coVID-19 disease showed a gradual decrease in type 1 (antiviral) and type 3 (antifungal) responses.
-
Semin Arthritis Rheu: Craniotomy and extracranial cytomegaloblastthromatisis have similar HLA-DRB1 associations.
Time of Update: 2020-07-30
Similar to cranial GCA, the association is also attributed mainly to hlA-DRB1 x 04:01 allele (19.0% vs 5.3% ;p ,lt;0.01; OR (95% CI) s 4.15 (2.06-8.19), respectively).
cranial and LVV-GCA patients did not show differences in HLA-DRB1 allele.
-
Arthritis Rheumatol: Kanamono resistance and safety in sJIA patients.
Time of Update: 2020-07-30
On the 15th day of the , considerable efficacy was observed in two subgroups (aJIA-ACR 50/70/90/100) (fever group: 60.0%/48.6%/37.1%/24.3%; to the 6th month, 17 (24.3%) and 26 (37.1%) fever patients were CRJADAS and CRACR, respectively, compared with 9 (17.3%) and 12 (23.1%) without fever.
-
1 case of IgG4-related diseases was reported.
Time of Update: 2020-07-30
december 2016 to the local hospital, hematology results: low red blood cells, hemoglobin, platelet count, globulin continued to increase, bone marrow puncture results: bone marrow elephant in combination with his examination, consider pulp cell myeloma (smear seen 6.
-
Important research results focus on new advances in the field of peptide drug molecular research!
Time of Update: 2020-07-30
Photo credit: Science Translational Medicine, 2020, doi: 10.1126/scitranslmed.aaz7287 (Science Sub-journal: Using M3mP6 polypeptide high-load nanoparticles is expected to treat heart disease doi: 10.1126/sci In a new study, researchers at the University of Illinois at Chicago have developed a new drug that prevents blood clots and does not increase the risk of bleeding, a common side effect of all platelet drugs.
-
Sci Rep: Prevalence of neck and shoulder pain among public hospital staff and its associated factors.
Time of Update: 2020-07-30
Due to the lack of NSP data, the study investigated the prevalence of NSP and sick leave absences among staff at public hospitals in Shandong, China, and looked at the factors associated with chronic NSP.
-
JAK inhibitor Rinvoq treatment of specific dermatitis: Phase III clinically showed significant efficacy.
Time of Update: 2020-07-30
Photo Source: At the 16th week, patients treated with 15 mg/30 mg of Rinvoq in two doses compared to placebo, had a significant increase in skin removal rate and itchreduction reduction, with 60% and 73% of patients reaching EASI 75, respectively, compared to 13% of the placebo group.